medmix Industry launches MIXPAC™ greenLine™ B‐System – the first cartridge with 100% recycled materials

31 March 2022

Putting its commitment to Sustainability into practice, medmix launches the first cartridge made from 100% post‐consumer recycled polypropylene (PCR PP), giving medmix customers a new option to reduce their environmental impact and meet their sustainability goals.

For medmix, the launch of the new MIXPAC™ greenLine 50 mL B‐System Set represents the next phase in environmentally friendly solutions developed over the last years, following its long-standing record as a leading manufacturer of two‐component mixing and dispensing systems.

MIXPAC™ greenLine™ cartridge

The PCR PP‐cartridge of the MIXPAC™ greenLine B‐System was developed using eco-design principles, reducing CO2 footprint by 36% in comparison to standard cartridges. Thanks to a smart concept of recycled packaging, the greenLine solution also reduces packaging waste. Moreover, the compatibility of the greenLine solution with a wide complete range of industrial application possibilities plays an important role: the selection of the optimal mixer for each type of application minimizes the material waste.

In addition to the significant environmental advantages of the new cartridge generation, the MIXPAC™ greenLine 50 mL B‐System Set combines the high‐end features of our established and successful range: The modular concept ensures a controlled, reproducible adhesive process with the utmost process safety. Designed for many industrial adhesive and sealant applications with Epoxy and Polyurethane systems, the greenLine innovation enables a precise metering and fatigue‐free operation. Users will appreciate in the easy‐to‐use handling, intuitive positioning and exchange of the robust PCR PP‐cartridge.

MIXPAC™ greenLine™ 50 mL B‐System Set

medmix is a global leader in high-precision delivery devices. We occupy leading positions in the healthcare, consumer and industrial end-markets. Our customers benefit from a dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 12 production sites worldwide together with our highly motivated and experienced team of 1’900 employees provide our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX).

This document may contain forward-looking statements including, but not limited to, projections of financial developments, market activity, or future performance of products and solutions containing risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors that could cause actual results or performance to differ materially from the statements made herein.